University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Med Arch. 2022 Apr;76(2):84-89. doi: 10.5455/medarh.2022.76.84-89.
Acute coronary syndrome (ACS) includes a group of different clinical conditions resulting from acute ischemia and/or myocardial necrosis and may manifest as: unstable angina pectoris, acute myocardial infarction without and with ST-segment elevation on electrocardiography (ECG), or as sudden cardiac death. Their mutual differentiation is based, with clinical findings and ECG characteristics, on laboratory confirmation or exclusion of myocardial necrosis on the basis of obtained values of highly sensitive and specific cardiac troponins T or I. Troponin I is a widespread marker in clinical use that possesses almost 100% specificity for myocardial tissue and is used as a highly sensitive marker even in the case of microscopically small lesions of cardiac tissue necrosis.
To investigate the association of inflammatory and hemostatic parameters with values of high sensitive troponin I (hsTnI) in patients with acute coronary syndrome.
The prospective study included 82 patients with a clinical condition of acute coronary heart disease (stable angina pectoris 23, acute coronary syndrome 59, of which 35 had non-STEMI elevation infarction and 24 had ST-segment elevation infarction (STEMI). The values of hsTnI had been measured in all patients and correlated with values of inflammatory (c reactive protein-CRP, leukocytes, neutrophils, lymphocytes, neutrophil/lymphocyte ratio) and hemostatic (platelet counts, mean platelet volume-MPV) parameters.
Patients with acute coronary syndrome had significantly higher values of hsTnI, and inflammatory parameters: CRP, leukocytes and neutrophils (absolute number and percentage) as well as the neutrophil /lymphocyte ratio compared to patients with stable angina pectoris. In patients with ACS, hsTnI has significantly correlated with CRP (r=0.5; p=0.00), leukocytes (r=0.3; p=0.020) and absolute neutrophil count (r=0.27; p=0.039). In patients with non-STEMI, a significant correlation was found between hsTnI and MPV (r=0.359; p=0.034), while in the STEMI group a significant correlation existed between hsTnI and CRP (r=0.422; p=0.40), and neutrophil /lymphocyte ratio (r =0.511; p=0.011).
Markers of inflammation may help in early risk stratification in patients with acute coronary syndrome.
急性冠状动脉综合征(ACS)包括一组不同的临床病症,这些病症由急性缺血和/或心肌坏死引起,可能表现为不稳定型心绞痛、无心电图(ECG)ST 段抬高的急性心肌梗死、有心电图 ST 段抬高的急性心肌梗死或心源性猝死。它们的相互区分是基于临床发现和心电图特征,通过实验室检测获得的高度敏感和特异性肌钙蛋白 T 或 I 来证实或排除心肌坏死。肌钙蛋白 I 是一种广泛应用于临床的标志物,对心肌组织具有近 100%的特异性,甚至在心肌组织坏死的显微镜下微小病变时也可用作高度敏感的标志物。
探讨炎症和止血参数与急性冠状动脉综合征患者高敏肌钙蛋白 I(hsTnI)值的关系。
前瞻性研究纳入了 82 例临床诊断为急性冠状动脉疾病的患者(稳定型心绞痛 23 例,急性冠状动脉综合征 59 例,其中非 ST 段抬高型心肌梗死 35 例,ST 段抬高型心肌梗死 24 例)。所有患者均检测了 hsTnI 值,并与炎症(C 反应蛋白-CRP、白细胞、中性粒细胞、淋巴细胞、中性粒细胞/淋巴细胞比值)和止血(血小板计数、平均血小板体积-MPV)参数进行了相关性分析。
与稳定型心绞痛患者相比,急性冠状动脉综合征患者的 hsTnI 值以及炎症参数(CRP、白细胞和中性粒细胞(绝对值和百分比)和中性粒细胞/淋巴细胞比值均显著升高。在 ACS 患者中,hsTnI 与 CRP(r=0.5;p=0.00)、白细胞(r=0.3;p=0.020)和绝对中性粒细胞计数(r=0.27;p=0.039)呈显著相关。在非 ST 段抬高型心肌梗死患者中,hsTnI 与 MPV 之间存在显著相关性(r=0.359;p=0.034),而在 ST 段抬高型心肌梗死患者中,hsTnI 与 CRP(r=0.422;p=0.40)和中性粒细胞/淋巴细胞比值(r=0.511;p=0.011)之间存在显著相关性。
炎症标志物可能有助于对急性冠状动脉综合征患者进行早期风险分层。